Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?

Rosj Gallicchio, Sabrina Giacomobono, Daniela Capacchione, Anna Nardelli, Francesco Barbato, Antonio Nappi, Teresa Pellegrino, Giovanni Storto

Research output: Contribution to journal › Article

Abstract

Remnant ablation by radioiodine is generally not recommended in patients presenting uni- or multifocal cancer

Original languageEnglish
Pages (from-to)426-433
Number of pages8
JournalEndocrine
Volume44
Issue number2
DOIs
Publication statusPublished - Oct 2013

Keywords

  • Differentiated thyroid cancer
  • Low-risk patients
  • Microcarcinoma
  • Radioiodine therapy
  • Remnant ablation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Access to Document

Fingerprint Dive into the research topics of 'Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?'. Together they form a unique fingerprint.

    • Cite this

    Gallicchio, R., Giacomobono, S., Capacchione, D., Nardelli, A., Barbato, F., Nappi, A., Pellegrino, T., & Storto, G. (2013). Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? Endocrine, 44(2), 426-433. https://doi.org/10.1007/s12020-013-9935-9